Abbott Diagnostics Technologies AS
Score · fiscal year 2024
74of 100
How to read this: the company is ahead of 92 % of companies in the Morning class Large in the same sector in 2024. What does this mean?
Rank in the Morning class Large: 25 of 294 · What are Morning company classes?
Place in the whole sector: 247 of 2,919 · Industri
Profile
Lion · Leader
High profitability, high solidity
Position against comparable companies in 2024, not a verdict on the company. Based on profitability 95 and solidity 86 out of 100 among companies in the Morning class Large in the same sector in 2024. Methodology
Against the sector
Abbott Diagnostics Technologies AS is 24 points above the median for companies in the Morning class Large in the same sector in 2024.
Median score 50 among 294 companies.
Against companies in the Morning class Large in the same sector in 2024: operating margin 21.9% (median 5.8%) and equity ratio 60.6% (median 33.1%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 1,986 MNOK | 1,092 MNOK |
| Operating margin | 21.9% | 5.8% |
| Profit margin | 24.7% | 5.6% |
| Return on assets | 38.6% | 11.9% |
| Equity ratio | 60.6% | 33.1% |
| Debt-to-equity | 0.65 | 2.04 |
| Current ratio | 1.08 | 1.28 |
| Revenue growth | 43.9% | 6.1% |
| Revenue per employee | 7.12 MNOK | 5.73 MNOK |
The median and “ahead of” refer to companies in the Morning class Large in the same sector in 2024. The bar shows the share of companies the figure is ahead of.
With an index of 74, Abbott Diagnostics Technologies AS does better than 92% of companies in the Morning class Large in the same sector (294 companies) in 2024.
Score 2023–2025
- Abbott Diagnostics Technologies AS
- Median: companies in the Morning class Large in the same sector
What the numbers say
Abbott Diagnostics Technologies AS had an operating margin of 21.9% and an equity ratio of 60.6% in 2024, and ranks 247 of 2,919 in Industri.
From 2023 to 2024: the operating margin rose from −0.5% to 21.9% and revenue grew by 44%.
This text is generated automatically from the 2024 accounts.
Three simple methods
The methods give between 822 MNOK and 3,824 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 3,824 MNOK |
| EV/EBIT | 8.0 | 3,493 MNOK |
| P/B | 1.0 | 822 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
- watch
Strong growth with weak liquidity. Is the growth financed, or does it tie up capital the company does not have?
Based on: Revenue growth 43.9% (median 6.1%); Current ratio 1.08 (median 1.28).
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 6.3% of the debt in 2024. The policy rate averaged 4.50 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2022, the sector's weakest year, for this company.
The sector's weakest year was 2022, with a median operating margin of 0.0%. Based on the 10 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 95 | weight 30% |
|---|---|---|
| Solidity | 86 | weight 25% |
| Liquidity | 29 | weight 15% |
| Growth | 90 | weight 15% |
| Consistency | 44 | weight 15% |
Durability: 63 (average over 2 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is Abbott Diagnostics Technologies AS?
The operating margin was 21.9% in 2024, against a median of 5.8% among companies in the Morning class Large in the same sector. Return on assets was 38.6%.
How solid is Abbott Diagnostics Technologies AS?
The equity ratio was 60.6% in 2024 (median 33.1%). Debt-to-equity was 0.65 (median 2.04).
What is the liquidity of Abbott Diagnostics Technologies AS like?
The current ratio was 1.08 in 2024 (median 1.28).
How does Abbott Diagnostics Technologies AS compare in Industri?
Abbott Diagnostics Technologies AS ranks 247 of 2,919 in Industri for 2024. Among companies in the Morning class Large it is number 25 of 294. Revenue changed by 43.9% from the year before.
From the Central Coordinating Register
- Org. no.
- 981363019
- Legal form
- AS
- Sector
- Industri (21.200)
- Morning company class
- Large
- Employees
- 279 registered 10 October 2026
- Founded
- 6 December 1999 26 years in operation
- Share capital
- 2.00 MNOK
- Business address
- Kjelsåsveien 161, 0884 OSLO
- Municipality
- Oslo rank 63–220 of 357 in Norway
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
Loading roles …
Source: Central Coordinating Register, fetched 31 October 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 31 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 52 | 74 | 45 | |
| Rank | 1,315 | 247 | 1,799 | |
| Operating margin | −0.5% | 21.9% | 8.3% | |
| Return on assets | 8.0% | 38.6% | 14.2% | |
| Equity ratio | 79.2% | 60.6% | 50.3% | |
| Current ratio | 1.47 | 1.08 | 1.00 | |
| Revenue growth | – | 43.9% | −12.7% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 1,380.1 MNOK | 1,985.8 MNOK | 1,734.1 MNOK |
| Operating profit | −6.5 MNOK | 435.4 MNOK | 144.7 MNOK |
| Profit before tax | 78.8 MNOK | 489.9 MNOK | 151.6 MNOK |
| Net profit | 62.3 MNOK | 382.4 MNOK | 118.9 MNOK |
| Financial expenses | 48.4 MNOK | 33.8 MNOK | 29.7 MNOK |
| Total assets | 1,596.1 MNOK | 1,357.3 MNOK | 1,281.3 MNOK |
| Current assets | 487.1 MNOK | 579.1 MNOK | 635.5 MNOK |
| Equity | 1,264.9 MNOK | 822.3 MNOK | 644.2 MNOK |
| Retained earnings | 62.3 MNOK | 382.4 MNOK | 204.3 MNOK |
| Total liabilities | 331.2 MNOK | 535.0 MNOK | 637.2 MNOK |
| Current liabilities | 331.2 MNOK | 535.0 MNOK | 637.2 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 31 October 2026, accounts id 6285719.
Further
Similar companies
- Axel Andersen AS index 75, rank 225 · compare
- Moelven Våler AS index 75, rank 239 · compare
- Nogva Motorfabrikk AS index 74, rank 250 · compare
- Bergen Engines AS index 74, rank 272 · compare
- Sleipner Motor AS index 74, rank 276 · compare